Preparation and Characterization of Sustained Release Risperidone Loaded Eudragit Microparticles by Spray-Drying Technique

The goal of this work was to create novel risperidone-containing spray-dried microparticles using Eudragit® L100, a methacrylic polymer. Microparticles were designed with controlled release and enhanced in-vitro effects in mind and were meant to be taken orally. Spray-drying was used to create Eudragit® L100 microparticles loaded with risperidone. Risperidone-loaded Eudragit® L100 was successfully prepared to treat mental/mood disorders, according to an investigation into its physicochemical properties in-vitro. Spray-drying was an effective method for producing Eudragit® L100 microparticles loaded with risperidone. Formulations displayed a suitable drug entrapment percentage or nearly 89.94%. The mean diameter of the nearly spherical and spherical microparticles ranged from 30 to 50 μm, and they had a smooth surface. The distinctive peak of risperidone loaded with Eudragit L100 was visible in the fourier-transformed infrared (FTIR) spectra, indicating that the medication was fully encapsulated in the polymer. The dissolution rate of risperidone-loaded microparticles was slower than that of the pure medication. The use of spray-dried risperidone microparticles as a practical oral drug delivery method for more effective and regulated risperidone release is supported experimentally by our results.